![](/images/general/no_picture/200_user.png)
Howard J Sanders
Examiner (ID: 15220, Phone: (571)270-3096 , Office: P/3653 )
Most Active Art Unit | 3653 |
Art Unit(s) | 3658, 3653 |
Total Applications | 914 |
Issued Applications | 683 |
Pending Applications | 65 |
Abandoned Applications | 166 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17593483
[patent_doc_number] => 20220143056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 17/584129
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/584129 | METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES | Jan 24, 2022 | Pending |
Array
(
[id] => 17702835
[patent_doc_number] => 20220202841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => DERMATOLOGICAL FORMULATIONS FOR TREATMENT OF DERMATITIS
[patent_app_type] => utility
[patent_app_number] => 17/559187
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17559187
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/559187 | DERMATOLOGICAL FORMULATIONS FOR TREATMENT OF DERMATITIS | Dec 21, 2021 | Pending |
Array
(
[id] => 17945836
[patent_doc_number] => 20220332853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => MANUFACTURING PROCESS FOR CYCLODEXTRIN DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/555286
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29521
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555286
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/555286 | MANUFACTURING PROCESS FOR CYCLODEXTRIN DERIVATIVES | Dec 16, 2021 | Pending |
Array
(
[id] => 17748112
[patent_doc_number] => 20220226315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => SYNERGISTIC COMBINATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/527084
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527084
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527084 | SYNERGISTIC COMBINATIONS AND METHODS OF USE | Nov 14, 2021 | Pending |
Array
(
[id] => 17748114
[patent_doc_number] => 20220226317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => SYNERGISTIC COMBINATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/527087
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527087
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527087 | SYNERGISTIC COMBINATIONS AND METHODS OF USE | Nov 14, 2021 | Pending |
Array
(
[id] => 17748113
[patent_doc_number] => 20220226316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => SYNERGISTIC COMBINATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/527085
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527085
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527085 | SYNERGISTIC COMBINATIONS AND METHODS OF USE | Nov 14, 2021 | Pending |
Array
(
[id] => 17414018
[patent_doc_number] => 20220048922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => COMPOUNDS TARGETING PRMT5
[patent_app_type] => utility
[patent_app_number] => 17/452689
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17452689
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/452689 | COMPOUNDS TARGETING PRMT5 | Oct 27, 2021 | Abandoned |
Array
(
[id] => 17412712
[patent_doc_number] => 20220047616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => Method and Compositions for Treating HTLV-1 Virus Infection
[patent_app_type] => utility
[patent_app_number] => 17/512183
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17512183
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/512183 | Method and Compositions for Treating HTLV-1 Virus Infection | Oct 26, 2021 | Abandoned |
Array
(
[id] => 17727734
[patent_doc_number] => 11384109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Method for separating phenolic acid glucoside compounds from
[patent_app_type] => utility
[patent_app_number] => 17/506985
[patent_app_country] => US
[patent_app_date] => 2021-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 3308
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506985
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/506985 | Method for separating phenolic acid glucoside compounds from | Oct 20, 2021 | Issued |
Array
(
[id] => 17532353
[patent_doc_number] => 20220110962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => ANALOGUES OF OLEUROPEIN AND OLEACEIN AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/500099
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500099
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/500099 | ANALOGUES OF OLEUROPEIN AND OLEACEIN AND USES THEREOF | Oct 12, 2021 | Abandoned |
Array
(
[id] => 17642323
[patent_doc_number] => 20220170061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => METHODS FOR PURIFICATION OF MESSENGER RNA
[patent_app_type] => utility
[patent_app_number] => 17/450506
[patent_app_country] => US
[patent_app_date] => 2021-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17450506
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/450506 | METHODS FOR PURIFICATION OF MESSENGER RNA | Oct 10, 2021 | Pending |
Array
(
[id] => 17480541
[patent_doc_number] => 20220088045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => Treatment compositions
[patent_app_type] => utility
[patent_app_number] => 17/483654
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17483654
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/483654 | Treatment compositions | Sep 22, 2021 | Abandoned |
Array
(
[id] => 17460346
[patent_doc_number] => 20220073651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => METHOD FOR PRODUCING HYDROGELS
[patent_app_type] => utility
[patent_app_number] => 17/480571
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480571
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480571 | METHOD FOR PRODUCING HYDROGELS | Sep 20, 2021 | Abandoned |
Array
(
[id] => 17426813
[patent_doc_number] => 20220054521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => Method and Compositions for Treating Coronavirus Infection
[patent_app_type] => utility
[patent_app_number] => 17/473594
[patent_app_country] => US
[patent_app_date] => 2021-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17473594
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/473594 | Method and Compositions for Treating Coronavirus Infection | Sep 12, 2021 | Pending |
Array
(
[id] => 17443701
[patent_doc_number] => 20220064206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => DEVICES AND METHODS FOR SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 17/458200
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17458200
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/458200 | DEVICES AND METHODS FOR SYNTHESIS | Aug 25, 2021 | Pending |
Array
(
[id] => 17300067
[patent_doc_number] => 20210395906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY
[patent_app_type] => utility
[patent_app_number] => 17/410135
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410135
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/410135 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | Aug 23, 2021 | Pending |
Array
(
[id] => 17563505
[patent_doc_number] => 20220127654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => ALPHA-1,3-GLUCAN GRAFT COPOLYMERS
[patent_app_type] => utility
[patent_app_number] => 17/406386
[patent_app_country] => US
[patent_app_date] => 2021-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17406386
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/406386 | Alpha-1,3-glucan graft copolymers | Aug 18, 2021 | Issued |
Array
(
[id] => 17426821
[patent_doc_number] => 20220054529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => HEMOSTATIC AGENT AND METHOD OF PRODUCTION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/404688
[patent_app_country] => US
[patent_app_date] => 2021-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17404688
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/404688 | Hemostatic agent and method of production thereof | Aug 16, 2021 | Issued |
Array
(
[id] => 17576845
[patent_doc_number] => 20220133700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/397216
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17397216
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/397216 | COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS | Aug 8, 2021 | Pending |
Array
(
[id] => 18076296
[patent_doc_number] => 20220401908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => Aerogel Based on Gas Vesicles and Bacterial Cellulose
[patent_app_type] => utility
[patent_app_number] => 17/391352
[patent_app_country] => US
[patent_app_date] => 2021-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5917
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17391352
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/391352 | Aerogel Based on Gas Vesicles and Bacterial Cellulose | Aug 1, 2021 | Pending |